Phase 3 Lung Cancer Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People who are 18 years of age or older at the time of joining the trial.
- People whose general health and ability to carry out daily activities falls within a certain range, as measured by a standard oncology scoring tool called the ECOG scale (scores 0–2, meaning fully active to capable of limited self-care — confirm with trial site if unsure where someone falls on this scale).
- People who are expected to live for at least 6 months.
- People who have been confirmed through tissue or cell testing to have a specific type of advanced (stage IV) lung cancer — non-squamous non-small cell lung cancer (NSCLC) — that has spread to other parts of the body, cannot be removed by surgery, and cannot be cured with current treatments, and whose cancer does not have certain gene changes (driver gene-negative).
- People who have not yet received any chemotherapy given throughout the body (systemic chemotherapy) for their advanced lung cancer.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who have conditions that affect how the body absorbs food or medication through the digestive system, such as difficulty swallowing, poor nutrient absorption, previous stomach removal surgery, or vomiting that cannot be controlled; or who are currently on tube feeding or intravenous nutrition; or who have anorexia nervosa, an eating problem caused by a psychiatric condition, or an inability to eat due to pain.
- People whose lung cancer is driven by specific gene changes (driver gene-positive), or whose cancer has been confirmed through testing to be mainly squamous cell type.
- People who have Cushing's syndrome, problems with the adrenal or pituitary glands, or diabetes that is not well controlled.
- People who are currently taking part in another clinical trial that involves an active treatment or intervention (observational studies or the follow-up stage of a previous trial may be acceptable — confirm with trial site).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 13986252286
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Proportion of appetite improvement assessed by A/CS-12 (Anorexia/Cachexia Subscale of Functional Assessment of Anorexia/Cachexia Therapy); Proportion of individuals with weight gain exceeding 5% relative to baseline
Can't join this trial?
Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.